• Budget Impact Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Sofosbuvir For The Treatment Of Hepatitis C In The Veneto Region, Italy

    Nov 1, 2014, 00:00

  • Assessment Of Knowledge Regarding Diabetes- A Comparative Analysis Of Diabetes Patients And Healthy Population Of Quetta City, Pakistan

    Nov 1, 2014, 00:00

  • Treatment Effect Heterogeneity in Clinical Trials- An Evaluation of 13 Large Clinical Trials Using Individual Patient Data

    Nov 1, 2014, 00:00

  • Survival Status in (Pharmaco) Epidemiological Studies can be Successfully Investigated Using Administrative Residential Registries

    Nov 1, 2014, 00:00

  • Understanding the Payer Dilemma with Biosimilar Mabs- Striking the Right Balance Between Budget Needs and Patient Outcomes

    Nov 1, 2014, 00:00

  • Quality of Life and the Predictors of Thai Depressive Disorders Patients

    Nov 1, 2014, 00:00

  • The Econimic Cost of Rheumatoid Arthritis in Taiwan

    Nov 1, 2014, 00:00

  • Sources of Information and Pharmacists' Knowledge Regarding Rare Diseases and Orphan Drugs- Cross-Sectional Study In Serbia

    Nov 1, 2014, 00:00

  • Costs Related to Pneumonia, Meningitis and Sepsis in Patients 50 Years and Older from the Private Health System Perspective in Brazil

    Nov 1, 2014, 00:00

  • Nursing Diagnosis and Some Physiological Signs and Their Changes During the Arterial Hypertension

    Nov 1, 2014, 00:00

  • Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa

    Nov 1, 2014, 00:00

  • Assessing the Translatability of the Term “Frustrated”

    Nov 1, 2014, 00:00

  • Systematic Review of the Economics of Multiple Sclerosis in Latin America

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Protease Inhibitor Monotherapy Verse Ongoing Triple-Therapy in the Long-Term Management of HIV Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Human Papillomavirus Vaccination Programmes Parallel to Current Routine Vaccination of Young Teenage Girls

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors- Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Implications for Time Savings Using New Intraoperative Measuring Technology

    Nov 1, 2014, 00:00

  • Physicians Estimation Regarding The Impact Of Recession on Patient Adherence To Treatment In Diabetes Type 2 In Greece

    Nov 1, 2014, 00:00

  • Real-World Data on the Epidemiology and Treatment of HR +, HER2-Advanced Breast Cancer in Postmenopausal Patients in Different Regions of Russia for Forming Markov Models of Managment of Patients

    Nov 1, 2014, 00:00

  • Health Insurance Cost of Anxiety in Hungary- A Cost of Illness Study

    Nov 1, 2014, 00:00

  • Pain Therapy for Osteoarthritis in Germany- Analysis of Sickness Fund Claims Data

    Nov 1, 2014, 00:00

  • Selection of Topics For Nice Technology Appraisal 2005-2011- What Matters Most?

    Nov 1, 2014, 00:00

  • Encepp-HTA Working Group Survey on Capacity To Conduct Research in Support Of Health Technology Assessment

    Nov 1, 2014, 00:00

  • Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012

    Nov 1, 2014, 00:00

  • Does Not Reaching an Agreement on the Final Nice Scope Have Any Impact on The Final Apraisal Outcome?

    Nov 1, 2014, 00:00

  • A Database Analysis Of Patients Eligible For Second-Line Lipid-Lowering Treatment For Hypercholesterolaemia In England

    Nov 1, 2014, 00:00

  • A Gender Medicine Post-Hoc Analysis- Background and Methods of the Metagem Project

    Nov 1, 2014, 00:00

  • Does Giving Carers a Break Improve their Wellbeing? Results from an Evaluation using the EQ-5D-5L

    Nov 1, 2014, 00:00

  • Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany

    Nov 1, 2014, 00:00

  • Economic Evaluation of Bevacizumab Versus Ranibizumab in Neovascular Age-Related Macular Degeneration in China

    Nov 1, 2014, 00:00

  • Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared To Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors

    Nov 1, 2014, 00:00

  • Can Gastric Cancer Patients be Successfully Recruited for Clinical Phase III/IV and Health Outcome Studies Using Managed Physician Panels?

    Nov 1, 2014, 00:00

  • Chronic Care Management

    Nov 1, 2014, 00:00

  • Patterns of Asthma Treatment Utilization in Newly Diagnosed Elderly Patients are Inconsistent With Asthma Management Guidelines

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-To-Severe Active Rheumatoid Arthritis In Greece

    Nov 1, 2014, 00:00

  • A Comparison of Asian and Global Pharmaceutical Prices Using an EKS Method

    Nov 1, 2014, 00:00

  • Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Preventing the Progression to Type 2 Diabetes Mellitus in Adults at High Risk- A Systematic Review And Network Meta-Analysis of Lifestyle, Pharmacological and Surgical Interventions

    Nov 1, 2014, 00:00

  • Non-Proliferative Diabetic Retinopathy- is It Cost-Effective to Treat Early?

    Nov 1, 2014, 00:00

  • A Dutch Administrative Database in Support of Economic Evaluations- A Feasibility Study

    Nov 1, 2014, 00:00

  • Results of A Decubitus Prevention and Wound Care Project

    Nov 1, 2014, 00:00

  • Quality Of Life in Teenagers and Young Adolescent Patients With Diabetes Mellitus Type I With Insulin Pens Or Insulin Pumps In The Czech Republic

    Nov 1, 2014, 00:00

  • Identification of Dry Powder Inhaler Attributes, and their Relative Importance to Asthma and Chronic Obstructive Pulmonary Disease Patients, to Inform a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • The Valuation of EQ-5D-5L Health States in Korea

    Nov 1, 2014, 00:00

  • Self Reported Health Care Resource Use and Indirect Economic Burden of Opioid Induced Constipation (Oic)

    Nov 1, 2014, 00:00

  • The Oncology Pain Treatment Clinical Studies Quality Assessment

    Nov 1, 2014, 00:00

  • Cost–Effectiveness of Clopidogrel-Aspirin Versus Aspirin Alone for Acute Tia and Minor Stroke

    Nov 1, 2014, 00:00

  • Instructions for Authors

    Nov 1, 2014, 00:00

  • The Effectiveness Of Carotid Artery Stenting Compared With Endarterectomy In Symptomatic Patients With Carotid Stenosis In Korean Multi-Center Setting

    Nov 1, 2014, 00:00

  • Histoculture Drug Response Assay in Colorectal Cancer

    Nov 1, 2014, 00:00

  • The Reimbursement of Expensive Drugs In Hospitals in Western European Countries

    Nov 1, 2014, 00:00

  • Awareness and Interest in the United States Health Insurance Marketplace

    Nov 1, 2014, 00:00

  • Smoking Cessation Treatment Patterns and Characteristics of Patients with Copd Who are Attempting to Quit in Urban China

    Nov 1, 2014, 00:00

  • Survival After Locoregional Recurrence or Second Primary Breast Cancer- Impact of the Disease-Free Interval

    Nov 1, 2014, 00:00

  • Health Economic Model On the Costs and Effects of Rotavirus Vaccination in Romania

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France

    Nov 1, 2014, 00:00

  • A Cost Effectiveness Analysis of Everolimus Plus Exemestane Compared to Chemotherapy Agents for the Treatment of ER+ HER2- Metastastic Breast Cancer in the United Kingdom

    Nov 1, 2014, 00:00

  • Impact of Morbidity in Populations of North London Clinical Commissioning Groups on Patient Admission Rates and Gp Referrals

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Para-Aortic Lymphadenectomy Before Chemoradiotherapy in Locally Advanced Cervical Cancer

    Nov 1, 2014, 00:00

  • Potential Efficency and Cost Savings To the English Nhs By A Laparoscopic Aproach To Total Abdominal Hysterectomy

    Nov 1, 2014, 00:00

  • Impact of Patient Programs On Adherence In Inflammation and Immunology- A Global Systematic Review and Meta-Analysis of Published Evidence

    Nov 1, 2014, 00:00

  • In Vitro Drug Release and Ex Vivo Permeation Study of Prepared Mouth Dissolving Tablets of Fluconazole Through Porcine Buccal Mucosa

    Nov 1, 2014, 00:00

  • Assessment of Health States and Erectile Dysfunction-Associated Quality of Life Among Adult Males and Females With Male Partners in Germany, the United Kingdom and the United States

    Nov 1, 2014, 00:00

  • Cost of Non Small Cell Lung Cancer by Vietnamese and European Treatment Standards in Vietnam

    Nov 1, 2014, 00:00

  • Health Implications of the MTM Eligibility Criteria In The Affordable Care Act Across Racial And Ethnic Groups

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Celecoxib and Non Selective Non Steroidal Anti-Inflammatory Drug (Nsaid) Therapy for the Treatment of Osteoarthritis in Spain- A Decision-Tree Model

    Nov 1, 2014, 00:00

  • An Analysis of the Drivers of Pricing Premiums Granted to Innovative Products in Japan

    Nov 1, 2014, 00:00

  • Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv)

    Nov 1, 2014, 00:00

  • Assessing the Relationship Between Treatment Effect and Baseline Risk in Network Meta-Analsysis of Moderate to Severe Chornic Plaque Psoriasis Trials

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Posaconazole Versus Fluconazole or Itraconazole in the Prophylaxis of Invasive Fungal Infections Among Neutropenic Patients in Thailand

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life Among Tuberculosis Patients in Pakistan- A Cross Sectional Study Using WHOQOL-BREF

    Nov 1, 2014, 00:00

  • Resource Use and Health Care Costs of Cervical Lesions and Cervical Cancer in Slovakia

    Nov 1, 2014, 00:00

  • Burden of Drug Waste in Oncology- Optimization of Resource Use

    Nov 1, 2014, 00:00

  • Persistence in Open and Closed Data Sources- A Study of Fingolimod Verse Interferons/Glatiramer Acetate in Patients with Multiple Sclerosis

    Nov 1, 2014, 00:00

  • The Performance- Volume Limit Decreased the DRG Based Acute Care Hospital Financing in hungary

    Nov 1, 2014, 00:00

  • Which Metric To Choose For Indirect Comparison Of Treatments When Multiple Comparisons Are Feasible- Lubiprostone Verse Prucalopride In Chronic Constipation

    Nov 1, 2014, 00:00

  • Role of Corticosteroids Use in Ards- Comparison of Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Belimumab for the Treatment of Systemic Lupus Erythematosus (Sle) In Gree A Cost-Effectiveness and Cost-Utility Analysis

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Five New Antidepression Drugs A Network Meta Analysis

    Nov 1, 2014, 00:00

  • Assessing the Effectiveness AND Cost-Effectiveness of Audit and Feedback on Physician's Prescribing Indicators

    Nov 1, 2014, 00:00

  • Burden of Varicella in Asia-Pacific Countries- A Systematic Review and Critical Analysis

    Nov 1, 2014, 00:00

  • A Systematic Review of Health State Utility Values for Advanced Ovarian Cancer

    Nov 1, 2014, 00:00

  • Predictors of Working Motivation in Job Satisfaction Among Nurses in Cyprus

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Fulvestrant in the Treatment of Metastatic Breast Cancer in Second-Line Chemotherapy

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Dapagliflozin In Combination With Insulin for the Treatment of Type 2 Diabetes Mellitus (T2dm) In Spain

    Nov 1, 2014, 00:00

  • Health Economic Models in Alzheimer's Disease- A Critical Assessment

    Nov 1, 2014, 00:00

  • A Systematic Search and Methodological Review of Economic Models of Analgesics for Chronic Pain

    Nov 1, 2014, 00:00

  • The Pension Costs of Musculoskeletal Diseases. Estimation of the Economic Burden Borne by the Italian Social Security System

    Nov 1, 2014, 00:00

  • Real-World Cost-Utility Evaluation of Multiple Myeloma Treatments In Stem Cell Transplanted Patients

    Nov 1, 2014, 00:00

  • Cost of Health Care Services Offered by Parkinson Disease Associations in Spain

    Nov 1, 2014, 00:00

  • The Determinants of Uptake and Diffusion of Innovative Health Technologies. An Empirical Analysis

    Nov 1, 2014, 00:00

  • Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up- Prefer In Af Registry

    Nov 1, 2014, 00:00

  • Pharmaceutical Market Access in Emerging Markets Through Innovative Patient Access Schemes

    Nov 1, 2014, 00:00

  • Non-Interventional Research Ethical Requirements in England and Fran Shared Experience From A Binational Research Project

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of a Shingles Vaccination Program to Prevent Herpes Zoster And Post- Herpetic Neuralgia in the Spanish Setting

    Nov 1, 2014, 00:00

  • Towards Integration of Research Evidence on Patient Preferences in Coverage Decisions and Clinical Practice Guidelines- A Proposal for A Taxonomy of Preference-Related Terms

    Nov 1, 2014, 00:00

  • Cost Minimization Analysis Of Clinical Option Scenarios For Metformin And Acarbose In Treatment Of Type 2 Diabetes- Based On Direct And Indirect Treatment Comparison Results

    Nov 1, 2014, 00:00

  • A Cost-Analysis of Complex Radiotherapy in Patients with Head and Neck Cancer Results from the Art-Orl Study

    Nov 1, 2014, 00:00

  • ESTIMATED ECONOMIC BURDEN OF INSULIN INJECTION-RELATED LIPOHYPERTROPHY IN CHINESE PATIENTS WITH DIABETES

    Nov 1, 2014, 00:00

  • High BMI and Belly fat Correlate with Prevalence of Hypertension And Diabetes- A Cross Sectional Study In Sedentary Urban Popultaion Of Delhi

    Nov 1, 2014, 00:00

  • The Cost of Costing Treatments Incorrectly- Errors in the Application of Drug Prices in Economic Models Due to Differing Patient Weights

    Nov 1, 2014, 00:00

  • Nuedexta for the Treatment of Pseudobulbar Affect- Estimating the Financial Impact to the Scottish NHS

    Nov 1, 2014, 00:00

  • Patient-Reported Outcomes of Dipeptidyl Peptidase-4 Inhibitors- A Systematic Review

    Nov 1, 2014, 00:00

  • Quasi-Monte Carlo Simulation and Variance Reduction Techniques Substantially Reduce Computational Requirements of Patient-Level Simulation Models- an Application to a Discrete Event Simulation Model

    Nov 1, 2014, 00:00

  • The Effectiveness and Safety of Febuxostat - An Experience in Medical Center in Taiwan

    Nov 1, 2014, 00:00

  • The Importance of Long-Term Surveillance of Stage IB Melanomas- Unexpectedly Low Survival Subsequent to Recurrence

    Nov 1, 2014, 00:00

  • Evaluating Rates of Potential Generic Substitution for Prescription Drugs- Can We Improve On Existing Incentive Schemes?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness And Budget Impact Analyses Of Risk Stratification Of Patients With Moderate Risk Of Cardiovascular Events Using Lp-Pla2 Testing

    Nov 1, 2014, 00:00

  • New Observer-Reported Outcomes To Measure Treatment Satisfaction, Compliance, Palatability, and Gi Symptoms for Patients Needing Iron-Chelation Therapy

    Nov 1, 2014, 00:00

  • Economic Burden of Major Depressive Disorder (Mdd) in Five European Countries- Description of Resource use by Health State

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Lenalidomide-Plus-Dexamethasone in Multiple Myeloma Patients Who Have Received at Least One Prior Therapy- A South Korean Perspective

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin And Rivaroxaban In The Treatment Of Acute Pulmonary Embolism In The Uk

    Nov 1, 2014, 00:00

  • Market Analysis in Regard to Biologically Active Supplements And Medicines in Armenia

    Nov 1, 2014, 00:00

  • What are the Key Driving Factors Behind RSA Decisions In Australia?

    Nov 1, 2014, 00:00

  • Applying Multiple Criteria Decision Analysis in the Context of Health Technology Assessement- an Empirical Case Study

    Nov 1, 2014, 00:00

  • The Economic Value of Vaccination- Why Prevention Is Wealth

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania

    Nov 1, 2014, 00:00

  • Impacts of Epro Data Collection Mode Selection on Patient Inclusion

    Nov 1, 2014, 00:00

  • Are Prices of Patent-Protected Pharamceuticals in the Top 5 Eu Countries Converging?

    Nov 1, 2014, 00:00

  • Clinical and Demographics Characteristics of Non-Valvular Atrial Fibrillation Patients Switching From Warfarin To Novel Oral Anticoagulants

    Nov 1, 2014, 00:00

  • Care Needs for Rheumatoid Arthritis from Patient Perspectives- A Qualitative Study from Singapore General Hospital

    Nov 1, 2014, 00:00

  • Resources Utilization for the Investigation of Pulmonary Nodules in a University Hospital Center in Quebec, Canada

    Nov 1, 2014, 00:00

  • Long-Term Cost-Effectiveness Of Biphasic Human Insulin 30 In People With Type 2 Diabetes With Inadequate Glycaemic Control On Oral Antidiabetic Drugs In China

    Nov 1, 2014, 00:00

  • Knowledge of Human Papillomavirus among University Students in Hungary

    Nov 1, 2014, 00:00

  • Health State Utilities for Pressure Ulcers – A Comparison of Condition-Specific and Generic Measures and Time-Trade-Off (Tto)

    Nov 1, 2014, 00:00

  • Quality of Life Decrements after Stroke

    Nov 1, 2014, 00:00

  • A Systematic Review of Methods to Assess the Economic Impact of Air Pollution

    Nov 1, 2014, 00:00

  • Economic Evaluation of Home Parenteral Nutriton in Cancer Patients; The French Context

    Nov 1, 2014, 00:00

  • Health Related Quality of Life in Cancer Patients- Evaluation With A Self-Administered Ipad Application

    Nov 1, 2014, 00:00

  • Lipid Control After Percutaneous Coronary Intervention (PCI) in China

    Nov 1, 2014, 00:00

  • Real World Management and Costs in Unresectable Metastatic Melanoma (UMM) Patients Treated at the Antwerp University Hospital (UZA)

    Nov 1, 2014, 00:00

  • Ldl-C Lowering Efficacy of Evolocumab (Amg 145) Could Reduce Apheresis in Patients At High Risk for Cardiovascular Events in Germany

    Nov 1, 2014, 00:00

  • Comparing Access to Drugs Through the CDF and by Nice – The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage

    Nov 1, 2014, 00:00

  • Supporting Interoperable Eu Patient Registries- Survey of Registry Holders' Needs

    Nov 1, 2014, 00:00

  • Trends in Secondary Care Costs for Treatment of Head and Neck Cancer in England

    Nov 1, 2014, 00:00

  • Potentially Inappropriate Medication in the Elderly – Relevance and Economics of the 30 Top-Selling Priscus Agents in Germany

    Nov 1, 2014, 00:00

  • Trends in Physical and Occupational Therapy Utilziation in the Us And Western Europe

    Nov 1, 2014, 00:00

  • Evidence-Based Medicine as a Driver of Improving Colorectal Cancer Screening in Ukraine

    Nov 1, 2014, 00:00

  • A Cost-Consequence Analysis of Human Papillomavirus Vaccination in Romania

    Nov 1, 2014, 00:00

  • Assesment Of Serial Transverse Enteroplasty- Systematic Review

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of the Lidocaine 5% Medicated Plaster Verse Pregabalin and Amitriptyline for the Treatment of Post-Herpetic Neuralgia In the Netherlands

    Nov 1, 2014, 00:00

  • Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab Versus Photodynamic Therapy for the Treatment of Neovascluar Age-Related Macular Degeneration Based in China Cost Setting

    Nov 1, 2014, 00:00

  • UK Value-Based Assessment- Will Scotland's Smc Approach It In The Same Way?

    Nov 1, 2014, 00:00

  • How Successful Have Pediatric Investigation Plans Been In Stimulating Research For Pediatric Cancers?

    Nov 1, 2014, 00:00

  • Design Methods For Study Of Prevalence, Risk Factors And Economic Burden Of Insulin Injection-Related Lipohypertrophy In China

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Hypertensive Treatment With Indapamide And Amlodipine Single-Pill Combination In The Polish Setting

    Nov 1, 2014, 00:00

  • Do Specialty Drugs Offer Greater Value for Money Than Traditional Drugs?

    Nov 1, 2014, 00:00

  • Modeled Outcomes and Overall Costs of the 13-Valent Pneumococcal Conjugate Vaccine in the Tunisian National Vaccination Program

    Nov 1, 2014, 00:00

  • The Efficiency Evaluation of the Rule From Drug Market Regulation Chamber (Cmed) Proposed To Public Medicines Acquisitions

    Nov 1, 2014, 00:00

  • How do Organizational Arrangements of the Pharmaceutical Supply System Affect Availability to Essential Medicines in Rural China?

    Nov 1, 2014, 00:00

  • Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies

    Nov 1, 2014, 00:00

  • Systematic Review and Mixed Treatment Comparison of Lithium or an Atypical Anti-Psychotic (AAP) used to Augment a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)

    Nov 1, 2014, 00:00

  • The Impact of Cost Containment Reforms to the Pharmaceutical Benefits Scheme (Pbs) On Prescribing Volumes And Expenditure In Australia- 1992 To 2011

    Nov 1, 2014, 00:00

  • The Cost Burden of Community-Acquired Pneumonia in Russia in Adults of 50 and Older- A Regional Study and National Estimates

    Nov 1, 2014, 00:00

  • Data Sources of Disease Epidemiology in German Drug Reimbursement Dossiers- Case Study Of Diabetes Mellitus Type II

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Mycophelonate Sodium On Patients With Renal Transplant At The Public Mexican Health Care System

    Nov 1, 2014, 00:00

  • Using the Analytic Hierarchy Process To Derive Health State Utilities From Ordinal Preference Data

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Crizotinib Treatment In Alk+ Non-Small-Cell Lung Cancer Patients In Thailand

    Nov 1, 2014, 00:00

  • Economic Burden of Pediatric Atopic Dermatitis in Asia-Pacific- A Review of the Literature

    Nov 1, 2014, 00:00

  • Relative Efficacy And Safety of Ustekinumab Compared to Anti-TNF-Alfa Therapies in Patients With Active Psoriatic Arthritis

    Nov 1, 2014, 00:00

  • Market Access and Reimbursement- The Increasing Role of Real-World Evidence

    Nov 1, 2014, 00:00

  • The Burden Of Chronic Urticaria In Europe- A Systematic Literature Review

    Nov 1, 2014, 00:00

  • A Comparison of Factors Influencing Reimbursement and Coverage Decisions in Scotland (Smc), The Netherlands (Nzi) and Germany (G-Ba)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis In Portugal

    Nov 1, 2014, 00:00

  • Mapping from SF-6D to EQ-5D- Changes in Estimates Based on the Choice of Algorithm

    Nov 1, 2014, 00:00

  • Value in the Making- Harvesting the Value of Complex Medical Innovations in Practice

    Nov 1, 2014, 00:00

  • Development And Content Validity Testing Of A Treatment Acceptance Measure For Use In Hypercholesterolemia Patients Receiving Treatment Via Subcutaneous Injection

    Nov 1, 2014, 00:00

  • Choosing Important Health Outcomes For Comparative Effectiveness Research- A Systematic Review

    Nov 1, 2014, 00:00

  • Will Nurses Have Better Outcomes than Non-Medical Working Women when Hospitalized for Female Genital Diseases?

    Nov 1, 2014, 00:00

  • The Benefits and Challenges of Submitting to the Nice Medical Technologies Evaluation Programme-Manufacturer Perceptions And Experiences

    Nov 1, 2014, 00:00

  • Health State In Patients With Venous Thromboembolism On Conventional And Non-Vka Oral Anticoagulants As Assessed With The Eq-5d-5l Questionnaire- Prefer In Vte Registry

    Nov 1, 2014, 00:00

  • Resource use and Costs for Managing HCV Genotype 1 Patients in Colombia from the Payers Perspective

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease- Interim Results from the Sole Study

    Nov 1, 2014, 00:00

  • Can Using a Resource Use Log in an Economic Evaluation Alongside a Randomised Controlled Trial Reduce the Amount of Recall Bias?

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Assessment Of Apixaban Versus Standard Of Care For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Determination Of The Annual Health Insurance Cost Of Outpatient Care Physiotherapy Services For Low Back Pain

    Nov 1, 2014, 00:00

  • Patient Specific Landscape of Information Technology Solutions for Diabetes Self-Management

    Nov 1, 2014, 00:00

  • Will Value Based Assessment (VBA) Revolutionise The Nice Assessment?

    Nov 1, 2014, 00:00

  • Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing

    Nov 1, 2014, 00:00

  • The Long-Term Outcomes Of Bariatric Surgery On Patients With Type 2 Diabetes Mellitus- A Systematic Review And Meta-Analyses

    Nov 1, 2014, 00:00

  • Differences Between Hypothetical and Experience-Based Value Sets for Eq-5d- Implications for Decision Makers

    Nov 1, 2014, 00:00

  • Methods for Health Economic Evaluations of Vaccines – Results from an International Expert-Workshop

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Threshold For Orphan Designations in Poland Based on Reimbursement Decisions

    Nov 1, 2014, 00:00

  • Trends in Time To Market Access In Europe - Is It Getting Better?

    Nov 1, 2014, 00:00

  • Use Of External Data To Guide Long-Term Survival Extrapolations Of Trial Data For Chronic Lymphocytic Leukemia

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary – A Global Cost-Effectiveness Model Adaptation

    Nov 1, 2014, 00:00

  • Inpatient Case-Related Treatment Costs For Different Cardiovascular Diseases In Germany

    Nov 1, 2014, 00:00

  • A Systematic Literature Review on Risk Factors for Cervical Cancer in Chinese Population

    Nov 1, 2014, 00:00

  • Multi-Criteria Decision Analysis for Reimbursing Orphan Drugs- A Dutch Demonstration Study Using the Analytic Hierarchy Process Method

    Nov 1, 2014, 00:00

  • Modification of Patient Reported Outcomes Measures of Compliance, Gastrointestinal Symptoms, Palatability and Treatment Satisfaction for Patients Needing Iron Chelation therapy

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in France

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Long-Term Outcomes of Sovaldi (SOFOSBUVIR) for the Treatment of Chronic Hepatitis C Infected (HCV) Patients from a Swedish Societal Perspective

    Nov 1, 2014, 00:00

  • Hta Epidemiology Data in Different Geographical Regions- Investigation of Requirements For Oncology Drugs

    Nov 1, 2014, 00:00

  • The Comparison of the Risk-Sharing Schemes Proposed in Reimbursement Applications Received By Ahtapol In 2012 and 2013

    Nov 1, 2014, 00:00

  • Survey Findings on Evaluation of Traumatologist's Workload in Mongolia

    Nov 1, 2014, 00:00

  • The Life and Death of the End of Life Treatment Appraisal Criteria in Nice Technology Appraisals?

    Nov 1, 2014, 00:00

  • Development of a Longitudinal National Football League Injury and Injury Impacts (L-NFL-III) Database

    Nov 1, 2014, 00:00

  • Knowledge of HIV Status of Adolescents and Young Adults Attending an Adolescent HIV Clinic in Accra, Ghana

    Nov 1, 2014, 00:00

  • HTA Informed Price Negotiations- Cost Savings To The Health Payer in Ireland

    Nov 1, 2014, 00:00

  • Budget impact analysis of peritoneal dialysis versus. Conventional in-center hemodialysis in malaysia

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab Verse Infliximab for the Patients With Rheumatoid Arthritis in Kazakhstan

    Nov 1, 2014, 00:00

  • Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland

    Nov 1, 2014, 00:00

  • The Cost Comparison Of Drug-Eluting Stents (Des) And Bare-Metal Stents (Bms) - A Retrospective Cohort Matched Study

    Nov 1, 2014, 00:00

  • The Impact Of Daytime And Nocturnal Non-Severe Hypoglycaemic Events On People With Diabetes In Turkey

    Nov 1, 2014, 00:00

  • Economic Evaluation of Agomelatine for Major Depressive Disorders Relative to other Antidepressants in the Italian Setting

    Nov 1, 2014, 00:00

  • An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)

    Nov 1, 2014, 00:00

  • Impact of 2011 German Health Care Reform on Prices

    Nov 1, 2014, 00:00

  • Quality of Diabetes Care Among Obese and Overweight Patients at Nhg Polyclinics

    Nov 1, 2014, 00:00

  • Implementation of Technologies Based on the Evidence-Based Medicine and Hta in the Management of Hepatitis C

    Nov 1, 2014, 00:00

  • Guidance For Economic Evaluation and Budget Impact Analysis For Pharmaceuticals in Catalonia (Spain)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of High-Sensitive Troponin Assays For The Early Rule-Out Or Diagnosis Of Acute Myocardial Infarction (Ami) In People With Acute Chest Pain- A Nice Diagnostic Assessment

    Nov 1, 2014, 00:00

  • Letting The Data Speak- A Shift of the Pharmaceutical Spending to Households in Greece

    Nov 1, 2014, 00:00

  • Hearing the Patient's Voice in Health Care- A Survey Analysis of Patients' Perceptions of Difficulties in Shared Clinical Decision-Making

    Nov 1, 2014, 00:00

  • Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • What is the Status of Health Related Quality of Life Among Medical Representatives in India?

    Nov 1, 2014, 00:00

  • Prescription of Rosiglitazone and Pioglitazone Folowing Safety Warnings- A Comparative Analysis of Trends in Dispensing Patterns in Denmark and Germany From 2007 To 2013

    Nov 1, 2014, 00:00

  • Cognitive Function And Non-Adherence To Antihypertensive Medications

    Nov 1, 2014, 00:00

  • Ten Years Of Development Studies In Health Technology Assessment In Brazil- Profile Of Studies And Operational Indicators

    Nov 1, 2014, 00:00

  • Avoiding and Identifying Errors and Other Threats To the Credibility of Health Economic Models

    Nov 1, 2014, 00:00

  • Analyses on Temporal and Spatial Clustering and Changing Trend of HCV in Mainland of China

    Nov 1, 2014, 00:00

  • Effectiveness of Heavy-Light Chain Quantitative Test- A Systematic Review

    Nov 1, 2014, 00:00

  • Understanding Caregiver Burden in Colorectal Cancer- What Role Do Patient And Carer Factors Play?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Antiviral Therapy for Chronic Hepatitis B- A Systematic Review

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Ustekinumab Compared With Etanercept for the Treatment of Moderate to Severe Psoriasis in Costa Rica

    Nov 1, 2014, 00:00

  • Hospitalization Costs Associated With Liver Cirrhosis

    Nov 1, 2014, 00:00

  • A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases

    Nov 1, 2014, 00:00

  • National Rare Disease Strategies- The Current State for Orphan Drug Market Access in European Union (Eu) Member States

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of A Short Message Service (Sms) Intervention To Prevent Type 2 Diabetes Among Adults With Impaired Glucose Tolerance

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Axial Spondyloarthritis in Clinical Practice In Sweden- Baseline Results From A Longitudinal Study

    Nov 1, 2014, 00:00

  • Measuring and Observing Positive And Negative Externalities Caused By Vaccines- Do We Have The Right Assessment Approach Available?

    Nov 1, 2014, 00:00

  • Assessment of Medication Adherence in Rheumatoid Arthritis Patients in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies

    Nov 1, 2014, 00:00

  • Non-Steroidal Anti-Inflammatory Drugs in Household Drug Supplies in Serbia

    Nov 1, 2014, 00:00

  • Predictive Modelling- Predicting Hospitalisation And Estimating The Cost And Risk To The Third Party Funder

    Nov 1, 2014, 00:00

  • Medication Counseling Beyond Instituitional- Impact Of Pharmacist-Led Home Medication Review In Type 2 Diabetes Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of the Treatment of Respiratory Diseases of Xiyanping Injection - A Systematic Review

    Nov 1, 2014, 00:00

  • Racial Disparities in Type 2 Diabetes Health Care Utilization in Medicaid Adults With Developmental Disabilities

    Nov 1, 2014, 00:00

  • Reimbursement Decisions in Oncology Drugs- An International Analysis

    Nov 1, 2014, 00:00

  • Guidance for Risk Sharing Agreements / Pay Per- Results SCHEMES FOR PHARMACEUTICALS IN CATALONIA (SPAIN)

    Nov 1, 2014, 00:00

  • Impact of Economic Crisis on the Greek Health Care System and on the Population Health

    Nov 1, 2014, 00:00

  • Predictors For Mortality Among Human Immunodeficiency Virus Infected Patients On Antiretroviral Therapy

    Nov 1, 2014, 00:00

  • Prevalence of Chronic Diseases Among Older Patients (>65 Years) in German General Practitioner Practices

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Colonic Stents for the Management of Malignant Large Bowel Obstruction

    Nov 1, 2014, 00:00

  • Validity of the Eq-5d-5l in Stroke Patients

    Nov 1, 2014, 00:00

  • A Kinematic Comparison of Overground and Treadmill Walking

    Nov 1, 2014, 00:00

  • A Budget Impact Analysis (Bia) Of The Use Of Paricalcitol For The Treatment Of Secondary Hyperparathyroidism (Shpt) In End Stage Renal Disease Patients

    Nov 1, 2014, 00:00

  • Cost and Burden Of Hypercholesterolemia In Portugal

    Nov 1, 2014, 00:00

  • What is the Most Cost-Effective Strategy for Treating Chronic Myeloid Leukemia After Imatinib Loses Patent Exclusivity in Europe?

    Nov 1, 2014, 00:00

  • Prescribing Patterns of General Practitioners (Gps) in Primary Health Care- Evidence From Greece

    Nov 1, 2014, 00:00

  • Estimating Overall Impact of Human Papillomavirus Vaccination on Cervical Cancer Burden in Spain and Portugal

    Nov 1, 2014, 00:00

  • Antidepressant use and Suicide Rate in England- the Geographic Divide

    Nov 1, 2014, 00:00

  • Comparison of Epidemiology and Drug Treatment in HER2 Negative Metastatic Breast Cancer (MBC) in EU5

    Nov 1, 2014, 00:00

  • Drug Access Through Sharing Public And Individual Responsibilities In The Public Health Care System Of Singapore

    Nov 1, 2014, 00:00

  • Are Patient Reported Outcomes Relevant To Patients? Learnings From A Patient Advocate Survey

    Nov 1, 2014, 00:00

  • Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia- Results from a Markov Model

    Nov 1, 2014, 00:00

  • Prevalence of Metabolic Syndrome in Patients with Schizophrenia According to the Presence or Absence of Negative Symptoms

    Nov 1, 2014, 00:00

  • Assessing The Relationship Between Individual Attributes Identified In Review Of Multi-Criteria Decision Analysis (MCDA) Of Rare Diseases And Annual Treatment Costs In Rare Endocrine Disorders

    Nov 1, 2014, 00:00

  • How Does Non-Malignant Opioid Induced Constipation (Oic) Impact Health State Utility?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis Of An Antimicrobial Transparent Dressing For Protecting Central Vascular Accesses In Critically Ill Patients Versus Standard Transparent Dressings In Fran A Comparison Of Two Modeling Approaches- Decision-Tree Ve ...

    Nov 1, 2014, 00:00

  • Predictive Modeling to Assess Predictors of Treatment Success and Failure Among Combination Statin Therapy Patients

    Nov 1, 2014, 00:00

  • Qualitative Assessment of the Quality of Pharmaceutical Care Services in the Province of Khyber Pakhtunkhwa, Pakistan- Hospital Pharmacists' Views

    Nov 1, 2014, 00:00

  • An Italian Oncology Research to Evaluate Adherence to Clinical Guidelines for Cancer Treatment- The Right Program

    Nov 1, 2014, 00:00

  • Efficacy of Treatments for Macular Oedema Secondary to Branch Retinal Vein Occlusion- A Network Meta-Analysis

    Nov 1, 2014, 00:00

  • Direct Non-Medical Costs Of Rheumatoid Arthritis By Disease Level In Portugal

    Nov 1, 2014, 00:00

  • The Impact Of Diabetes On Mortality In Inpatients From Medical Department Of A Chinese Tertiary Hospital

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Interventions Aimed at Decreasing The Number of Amputations Among Patients With Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Fidaxomicin Therapy for Patients with Clostridium Difficile Infection- A Systematic Literature Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Validation of the Adherence Barriers Questionnaire (Abq) – An Instrument for Identifying Potential Risk Factors Associated With Medication-Related Non-Adherence

    Nov 1, 2014, 00:00

  • Premixed Insulin Lispro Versus Insulin Glargine In Type 2 Diabetes- A Meta-Analysis

    Nov 1, 2014, 00:00

  • Product Quality Aspect in Reimbursement of Medical Devices- Comparison of Turkey Verse Europe

    Nov 1, 2014, 00:00

  • Calculating Indirect Costs – Differences Caused by Various Approaches to Unit Costs. Results of Move to Work Study (M2W)

    Nov 1, 2014, 00:00

  • Acute And Chronic Impact Of Cardiovascular Events On Health State Utilities

    Nov 1, 2014, 00:00

  • German Patients' Preferences for Attributes Of Type 2 Diabetes Medications

    Nov 1, 2014, 00:00

  • The Development and Preliminary Validation of the Manchester Early Morning Symptoms Index (Memsi) for People With Chronic Obstructive Pulmonary Disease (Copd)

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Ferric Carboxymaltose In Patients With Chronic Heart Failure And Iron Deficiency- An Analysis For Greece Based On Fair-Hf Trial

    Nov 1, 2014, 00:00

  • Price Comparison in the European Pharmaceutical Market

    Nov 1, 2014, 00:00

  • A DE-NOVO Model to Predict Outcomes of a New Hypothetical Intervention to Reduce CV Risk in Post Mi Patients

    Nov 1, 2014, 00:00

  • A Prospective, Cross-Sectional Study On Cost And Adherence Of Antidiabetic Prescriptions At A Tertiary Care Teaching Hospital In South India

    Nov 1, 2014, 00:00

  • Economic Evaluation of Nalmefene for the Treatment of Alcohol Dependence in Greece

    Nov 1, 2014, 00:00

  • Cost Effectiveness Of Renal Denervation Therapy For The Treatment Of Resistant Hypertension In The Netherlands

    Nov 1, 2014, 00:00

  • Boosting Biosimilars Uptake in European Countries

    Nov 1, 2014, 00:00

  • Analysis of Factors Causing Chronic Obstructive Pulmonary Disease in Eastern Region of China

    Nov 1, 2014, 00:00

  • Change in Percentage of Left Ventricular Ejection Fraction in Breast Cancer Patients Received Trastuzumab Treatment

    Nov 1, 2014, 00:00

  • The Grass is Always Greener on the Other Side or Why There Is Little Meaning in International Pharmaceutical Price Comparison

    Nov 1, 2014, 00:00

  • Demographics And Health Outcomes Associated With Adherence And Non-Adherence Among Type2 Diabetics In China

    Nov 1, 2014, 00:00

  • A Chart Abstraction Based Method to Classify Real World Patients With Pulmonary Arterial Hypertension Based on Who Functional Classification

    Nov 1, 2014, 00:00

  • Joint Modeling of Primary and Secondary Non-Adherence Outcomes

    Nov 1, 2014, 00:00

  • Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting

    Nov 1, 2014, 00:00

  • An Ethic System Overview- Brazilian Perspectives For Observational Studies

    Nov 1, 2014, 00:00

  • Bortezomib Re-treatment in Patients with Multiple Myeloma (MM). A Real World Medical Practice Experience from a Swedish National Registry

    Nov 1, 2014, 00:00

  • Systematic Review of Observational Studies and Rcts of Omalizumab in Severe Persistent Allergic Asthma and Meta-Analysis Feasibility Assessment

    Nov 1, 2014, 00:00

  • Should Cost-Effectiveness Analysis Include The Cost Of Consumption Activities? An Empirical Investigation

    Nov 1, 2014, 00:00

  • A Model to Estimate the Health System Burden of Prescription Opioid Abuse in Europe

    Nov 1, 2014, 00:00

  • Mapping May Cause Straining- The Inconsistent Relationship Between A Disease- Specific Questionnaire (Pac-Qol) And Eq-5d Mapping In Constipation

    Nov 1, 2014, 00:00

  • Modelling Longitudinal Trajectories of Patient-Reported Outcomes To Evaluate Treatment Effect

    Nov 1, 2014, 00:00

  • Drug Access Is Improved By The Essential Drug System And “Low-Priced Drug” Policy In China

    Nov 1, 2014, 00:00

  • Assessment Of The Huntington Quality Of Life Instrument (H-QOL-I) Cross-Cultural Validity

    Nov 1, 2014, 00:00

  • Patients' Acceptance of Their Medication- Results From a French Multi-Diseases Study With Patient Online Community Using the Acceptance By the Patients of Their Treatment (Accept©) Questionnaire

    Nov 1, 2014, 00:00

  • Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Analysis of Two Pegylated Interferon ALFA Treatment for Chronic HCV Infection in China

    Nov 1, 2014, 00:00

  • The Lumley-Method, A Recommended Network Meta-Analysis for Indirect Comparisons, Summarized for Practitioners

    Nov 1, 2014, 00:00

  • The Impact of the Income Per Capita in Chinese Family on Medical Expenditure

    Nov 1, 2014, 00:00

  • In-Patient Hospital Costs of Stroke- A Focused Literature Review

    Nov 1, 2014, 00:00

  • The Selection of Appropriate Health State Utility Values (Hsuvs) for Health Technology Assessment (Hta)- Lessons To Be Learnt

    Nov 1, 2014, 00:00

  • Drug Utilization Pattern for the Treatment of Septic Shock in the ICU- A Comparison Between Survivors and Non-Survivors in a Tertiary Care Teaching Institute

    Nov 1, 2014, 00:00

  • Functional Impairment and Cognitive Dysfunction in Depressed Patients in South-Korea- Results of Perform-K

    Nov 1, 2014, 00:00

  • Availability of Risk Sharing Agreements in the Turkish Pharmaceutical Sector

    Nov 1, 2014, 00:00

  • Clinical Outcome Assessment (Coa) Instrument Scoring- the Validity and Precision of Unweighted Summary Scores Verse Irt Weighted Scores, and the Added Value of Irt Standard Errors

    Nov 1, 2014, 00:00

  • Setting Targets For Public Spending Under Eu-Imf Assistance To Portugal - The Case Of Health Care and Pharmaceuticals

    Nov 1, 2014, 00:00

  • Preferences Regarding The Attributes Of Oral Anticoagulants In Patients With Atrial Fibrillation Results Of A Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • Saving Money in Health Care- Cost Effectiveness of Individual Drugs (As By Nice) Or Budget Cuts (As Under Pprs)?

    Nov 1, 2014, 00:00

  • Clinical and Economic Analysis of Effectiveness of Everolimus in the Treatment Of HR+, HER2- Advanced Breast Cancer in Russia

    Nov 1, 2014, 00:00

  • The Medical Costs of Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2014, 00:00

  • Development And External Validation Of A Risk Calculator For Predicting Anemia In Patients Treated With Triple Therapy (Tt) Containing Boceprevir (Boc), Pegylated Interferon And Ribavirin (Pr)

    Nov 1, 2014, 00:00

  • Collaborative Approach in Accessing Homogeneous Medical Data in Grid-Based Environment (Enhancing Diseases Classification)

    Nov 1, 2014, 00:00

  • Ten Years Outcomes in a Cohort of Patients Started on Antiretroviral Treatment in an Urban Clinic in Sub-Saharan Africa

    Nov 1, 2014, 00:00

  • Awareness of Hyperlipidemia Among University Students and Staff Member

    Nov 1, 2014, 00:00

  • Work Productivity Improvement Associated With Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results Of A Phase 3, Randomized, Controlled Trial

    Nov 1, 2014, 00:00

  • Pharmacy Cost Calculator for Hepatitis C Virus Patients in Turkey

    Nov 1, 2014, 00:00

  • WX-III-287-19 A Possible Thromboxane Antagonist in Bovine Coronary Arteries

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings

    Nov 1, 2014, 00:00

  • Risk of Bias in Trial-Based Economic Evaluations

    Nov 1, 2014, 00:00

  • Clinical Trials in Fran An Underexploited Opportunity

    Nov 1, 2014, 00:00

  • Initial Inappropriate Antibiotic Therapy in Hospitalized Patients with Gram-Negative Infections- Systematic Review And Meta-Analysis

    Nov 1, 2014, 00:00

  • Health Care use and Oral Medication Patterns for Type 2 Diabetes Patiets in China：The Role of Traditional Chinese Medicines

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of 2-DOSE AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia

    Nov 1, 2014, 00:00

  • Work Productivity Loss Due To Rheumatoid Arthtiris (Ra), Crohn's Disease (Cd) And Psoriasis (Ps) In Poland

    Nov 1, 2014, 00:00

  • The Incidence, Prevalence, and Survival of Malignant Melanoma in Taiwan

    Nov 1, 2014, 00:00

  • Comparative Effectiveness Research of Medical Devices – New Methods Needed?

    Nov 1, 2014, 00:00

  • Evidences and Criteria Related to the Hospital Service Quality and Safety

    Nov 1, 2014, 00:00

  • Economic Impact of Using Subcutaneous Trastuzumab

    Nov 1, 2014, 00:00

  • Inadequate Pain Relief Among Patients With Primary Knee Osteoarthritis - Analysis From The Portuguese Sample Of The Survey Of Osteoarthritis Real World Therapies (Sort)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Panitumumab Plus Mfolfox6 Versus Bevacizumab Plus Mfolfox6 for First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer

    Nov 1, 2014, 00:00

  • Cost of Pharmacotherapy in Polish Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Payer's Perceptions of Glucagon Kits Aimed at Reducing Administration Complexity During Severe Hypoglycemic Events

    Nov 1, 2014, 00:00

  • Assessment of Rural Health Purchasing Arrangements In China

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Modeling Of Antimicrobial Dressings For Preventing Catheter-Related Bloodstream Infection- Homogeneous Verse Non-Homogeneous Markov Approaches

    Nov 1, 2014, 00:00

  • Median Hospitalization Cost and Length of Stay for Carbapenem-Resistant Verse Carbapenem-Sensitive Patients in a Tertiary Care Hospital in South India

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Guangdong Rural Tertiary Breast Cancer Screening and Diagnosis System

    Nov 1, 2014, 00:00

  • Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort- A Patient Level Simulation Model

    Nov 1, 2014, 00:00

  • Uisess-B Oral Health Questionnaire Validity And Reliability In A Mexican Diabetic, Systemic Hypertension And Obese Patients

    Nov 1, 2014, 00:00

  • Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms- Use of “Number Needed to Treat” Analysis

    Nov 1, 2014, 00:00

  • Assessment of the Methodological Quality of Randomized Controlled Trials Published in "Russian Allergology Journal" in 2009-2013

    Nov 1, 2014, 00:00

  • Nice's Proposed Value-Based Assessment of Health Technologies- Concerns of Inconsistent Consideration of Social Values

    Nov 1, 2014, 00:00

  • Meta-Analysis of Decision Impact and Net Decision Change in Adjuvant Chemotherapy Allocation in Early Stage Node-Negative, Estrogen Receptor-Positive Breast Cancer with a 21-Gene Assay

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ipilimumab for Previously Untreated Patients with Advanced Metastatic Melanoma in Spain

    Nov 1, 2014, 00:00

  • Long Term Survival of Patients with Various Lung Cancer Histology in Seer Between 2004-2011

    Nov 1, 2014, 00:00

  • Hierarchical Network Meta-Analysis Incorporating Ordering Constraints on Increasing Doses of Interventions - Application to Overactive Bladder Syndrome

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Different Scenarios of Detecting of TB Among HIV-Infected People Depending on CD 4+ Count

    Nov 1, 2014, 00:00

  • The Health Economic Impact of Resource use in Dementia- the Erlanger Dementia Registry (EDR)

    Nov 1, 2014, 00:00

  • Systematic Review of Economic Evaluations in Cancerology In Brazil Between 1980 And 2013

    Nov 1, 2014, 00:00

  • ARE TOTAL HEALTH CARE EXPENDITURES IMPACTED BY A NEW DIABETES DIAGNOSTIC FACTOR- HBA1C?

    Nov 1, 2014, 00:00

  • Health Related Quality of Life Among Young Smokers

    Nov 1, 2014, 00:00

  • The Inverse Correlation Between Internal And External Risk Under International Reference Pricing- An Analysis of Six European Countries

    Nov 1, 2014, 00:00

  • Coverage Decision Framework in Asia Pacific- A Case Study of Targeted Cancer Medicines in the Treatment of Breast Cancer

    Nov 1, 2014, 00:00

  • Are Cycles Needed in Markov Models? – The Continuous Model as a Simpler Approach

    Nov 1, 2014, 00:00

  • Microsimulation Model For The Assessment Of Personalized Cancer Care- The Mapcca Model Framework

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Pentavalent Rotavirus Vaccine (Rv5) in Slovenia

    Nov 1, 2014, 00:00

  • Do new cancer drugs offer good value for money? the perspective of oncologists, payers, patients, and general population

    Nov 1, 2014, 00:00

  • Survey of Treatment Costs to Hepatitis C in China

    Nov 1, 2014, 00:00

  • Regulatory Issues in Pro Advertising- A Review of the Ddmac/Opdp Letters From 1998 To 2013 To Identify Pro Claims Violations and Examine Their Evolution Over Time

    Nov 1, 2014, 00:00

  • Characteristics of Patients With Systemic Lupus Erythematosus (Sle) Currently On Remission, With Active Disease But Not Experiencing Flare, and Those Experiencing Flares In Clinical Practices In Europe

    Nov 1, 2014, 00:00

  • Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room)- Clinical Outcomes in the Emergency Room

    Nov 1, 2014, 00:00

  • The Efficacy of Oximes in Acute Human Organophosphorus Poisoning; An Updated Meta-Analysis

    Nov 1, 2014, 00:00

  • Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets In Turkey

    Nov 1, 2014, 00:00

  • Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilisation Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy

    Nov 1, 2014, 00:00

  • Measuring Extent of Access For Nice Health Technology Assessment Decisions- Trends From 2008 to 2013

    Nov 1, 2014, 00:00

  • Costs Per Successfully Treated Patient with Sofosbuvir in GT1 HCV

    Nov 1, 2014, 00:00

  • A Cost Effectivness Analysis of Everolimus Compared with Axitinib in the Treatment of Metastatic Renal Cell Carcinoma in the United Kingdom

    Nov 1, 2014, 00:00

  • Cost Comparison Among First Line Monoclonal Antibodies-Based Oncology Treatment Protocols

    Nov 1, 2014, 00:00

  • The Impact of Discrimination, Victimization and Social Standing on Health-Related Quality of Life

    Nov 1, 2014, 00:00

  • Prospective Study on Cost-Effectiveness of Nurse Interviw Introducing Retesting With in Vitro Diagnostics (IVD) To Parents of Children With Suspected Food Allergy in Finland

    Nov 1, 2014, 00:00

  • Dose Titration, Persistence, and Adherence to Statin Therapy Among Patients with High-Risk Vascular Disease in Japan

    Nov 1, 2014, 00:00

  • The Pain Assessment for Lower Back Symptoms (Pal-S)- Refinement of A New Pro Instrument Through A Mixed Methods Approach

    Nov 1, 2014, 00:00

  • Rates of Diagnosed Opioid Abuse Or Dependence and Incremental Direct Health Care Costs Among Patients With Long-Term Use of Immediate Release Hydrocodone

    Nov 1, 2014, 00:00

  • Launching Novel Class Iii Implantable Cardiac Devices for Cardiology in Europe First, Is This Common Commercial Practice Improving Health Care Quality for Europeans

    Nov 1, 2014, 00:00

  • Comparison of Methods to Estimate Health State Utilities in Metastatic Breast Cancer (MBC)

    Nov 1, 2014, 00:00

  • Efficacy Of Novel Dmards In Early Active Rheumatoid Arthritis- An Indirect Comparison

    Nov 1, 2014, 00:00

  • Modeling the Effect of Combining Alogliptin With Dual therapy in Type 2 Diabetes

    Nov 1, 2014, 00:00

  • Whatever Happened To Nice Value-Based Pricing? Welcome, Value-Based Assessment

    Nov 1, 2014, 00:00

  • Quality of Life in Patients with Multiple Myeloma in Slovakia

    Nov 1, 2014, 00:00

  • Health Care Stakeholders' Evaluation of A User-Friendly Tool Which Estimates Long-Term Health Gains Following the Reduction of Ldl Levels

    Nov 1, 2014, 00:00

  • Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer

    Nov 1, 2014, 00:00

  • The Incidence Of Upper And Lower Gastrointestinal Complications- A Retrospective Study Using A Japanese Health Care Database

    Nov 1, 2014, 00:00

  • Estimating The Costs Of Specialist Out-Patient Services In A Public Hospital

    Nov 1, 2014, 00:00

  • Patient Preferences- Pro Mixed Modes – Epro Versus Paper

    Nov 1, 2014, 00:00

  • Evaluation of The Impact of Pharmaceutical Cognitive Service on Quality of Life in Diabetic Patients

    Nov 1, 2014, 00:00

  • Patient-Reported Fall Related Health Care Services in Elderly Women

    Nov 1, 2014, 00:00

  • Cost of Severe Hypoglycaemia in Hospitalized Patients In Poland- Is It Financed and Reported in a Right Way?

    Nov 1, 2014, 00:00

  • Everolimus Plus Exemestane Compared to Exemestane and Fulvestrant for the Treatment of ER+ HER2- Metastastic Breast Cancer in the United Kingdom – A Societal Perspective

    Nov 1, 2014, 00:00

  • When It May Not Be Necessary To Model Overall Survival for Economic Evaluations of Anti-Cancer Drugs

    Nov 1, 2014, 00:00

  • Simvastatin Plus Fenofibrate As A Fixed Dose Combination In The Treatment Of Mixed Dyslipidemia In Gree Budget Impact Analysis

    Nov 1, 2014, 00:00

  • Evaluation of the Economic Burden of Menopausal Women in the U. S. Medicaid Program

    Nov 1, 2014, 00:00

  • Coping with methicillin resistant staphylococcus aureus (MRSA) in german rehabilitation centers – are the incentives appropriate?

    Nov 1, 2014, 00:00

  • Results and implications of using a new eq-5d value set for cost-utility analyses in sweden. An application using enzalutamide (xtandi®) verse best supportive care for treatment of metastatic castration resistant prostate cancer (MCRPC)

    Nov 1, 2014, 00:00

  • Preferences of Spanish Patients Over the Attributes of Biological Agents for the Treatment of Rheumatic Diseases Depending On the Administration Route

    Nov 1, 2014, 00:00

  • A Systematic Review of Cost-Effectiveness Analysis of Cd4 Cell Count Verse Hiv Viral Load in Primarily Resource-Limited Setting

    Nov 1, 2014, 00:00

  • Patient Envolvement in Reimbursment of Drugs in Slovakia

    Nov 1, 2014, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98 (current)
  • 99
  • 100
  • »